cGxP.wire https://validator.w3.org/feed/docs/rss2.html Crescent Biopharma Advances CR-001 and ADC Cancer Pipeline Leads Biolabs Doses First Patient in Colorectal Cancer Trial Roche Wins FDA Approval for Enspryng in Thyroid Eye Disease insitro and AstraZeneca Partner on AI Drug Discovery Kedrion Calls for Earlier Diagnosis of Immune Deficiencies EltaMD Launches New Serum and Cream for Skin Recovery OMass Therapeutics Raises $310M to Advance Drug Pipeline Lunit AI Reveals HER2 Patterns Linked to Cancer Response Krystal Biotech Reports Broad BCC Regression With KB113 Immunocore Doses First Patient in Type 1 Diabetes Trial Salvia BioElectronics Begins Pivotal U.S. Trial of Migraine Implant Cellectar Reports Strong Iopofosine Data in Waldenström Macroglobulinemia Aquestive FDA Accepts Anaphylm NDA Resubmission for Review Seres Therapeutics Advances SER-428 for Bloodstream Infection Prevention Galderma Reports Year-Long Nemolizumab Benefits in Children Merz Completes Recruitment in Phase III XEOMIN Migraine Trials Vividion Launches Phase 2 Trial of WRN Inhibitor VVD-214 Mission Therapeutics Doses First Patient in MTX325 Parkinson’s Trial Viking Therapeutics Starts Oral VK2735 Phase 3 Obesity Trials Genezen and Galibra Advance SSADH Deficiency Gene Therapy 1cBio Receives Proceeds After BioMarin Acquires Alesta Kalohexis Strengthens Drug Research With New Scientific Advisors Caris Life Sciences Showcases AI Precision Oncology Research FibroBiologics Gains Australian Patent for Disc Regeneration Maverix Medical Wins FDA Clearance for Narwhal Pro Cryo SK Life Science Expands SUDEP Awareness and Research Support Florida Cancer Specialists Advances Two Cancer Drug Approvals Mighty Therapeutics Reports Barth Syndrome Pipeline Progress Galderma to Acquire ZO Skin Health in $1.5 Billion Deal Pierre Fabre FDA Accepts Tabelecleucel BLA Resubmission News MindMaze Reports Strong Home-Based Neurorehabilitation Results Suvoda Launches Sofia AI Assistant for Clinical Trials AbbVie Reports New SKYRIZI Data in Crohn’s Disease Telix Advances Cancer Theranostics Across Three Major Cancers Osivax Reports Phase 2b Results for OVX836 Flu Vaccine Cumulus and Transpharmation Align EEG for CNS Drug Trials Coya to Launch COYA 302 Extension Study in ALS in November Atara’s Tab-cel BLA Resubmission Accepted by FDA Viking Therapeutics Launches Phase 3 Oral Obesity Drug Trials Gore Wins FDA Approval for VBX Stent Graft in Aortic Repair Carnyx Therapeutics Unveils Oral Sleep Candidate CNYX-005 Vir Biotechnology and Gilead Sign $1.87B Oncology Collaboration Vantis Vascular Wins FDA Clearance for 6F CrossFAST Sarepta Reports 80% DMPK RNA Knockdown with SRP-1003 Propanc Biopharma Publishes PRP Cancer Study in Scientific Reports Cyted Health Reports Positive U.S. Validation Data for EndoSign Test NNB Nutrition Creatine Earns NSF Certified for Sport Status Takeda Launches ORZEYFUL in Japan and China for Narcolepsy JCR Pharmaceuticals Secures Kuwait Approval for IZCARGO ImmunityBio Wins Expanded FDA Approval for ANKTIVA in BCG-Unresponsive Bladder Cancer